OCUL - OCULAR THERAPEUTIX, INC

QQQ $ 617.98 $ 0.00 (0 %)

DIA $ 471.14 $ 0.00 (0 %)

SPY $ 674.63 $ 0.00 (0 %)

TLT $ 90.08 $ 0.00 (0 %)

GLD $ 365.26 $ 0.00 (0 %)

Previous Close

$ 10.9

Open

$ 11.20

Bid

$ 7.19 x 5

Ask

$ 11.40 x 1

Day's Range

-- - --

52 Week Range

$ 5.79 - $ 13.85

Volume

3,318,858

Average Volume

Market Cap

2.32B

Beta (5Y Monthly)

$ 1.41

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-04-2025	09-30-2025	10-Q
2	08-05-2025	06-30-2025	10-Q
3	05-05-2025	03-31-2025	10-Q
4	03-03-2025	01-01-1970	10-K
5	11-14-2024	09-30-2024	10-Q
6	08-07-2024	06-30-2024	10-Q
7	05-07-2024	03-31-2024	10-Q
8	03-11-2024	12-31-2023	10-K
9	11-07-2023	09-30-2023	10-Q
10	08-07-2023	06-30-2023	10-Q
11	05-08-2023	03-31-2023	10-Q
12	03-06-2023	12-31-2022	10-K
13	11-07-2022	09-30-2022	10-Q
14	08-08-2022	06-30-2022	10-Q
15	05-09-2022	03-31-2022	10-Q
16	02-28-2022	12-31-2021	10-K
17	11-08-2021	09-30-2021	10-Q
18	08-09-2021	06-30-2021	10-Q
19	05-05-2021	03-31-2021	10-Q
20	03-11-2021	12-31-2020	10-K
21	11-05-2020	09-30-2020	10-Q
22	08-07-2020	06-30-2020	10-Q
23	05-08-2020	03-31-2020	10-Q
24	03-12-2020	12-31-2019	10-K
25	11-12-2019	09-30-2019	10-Q
26	08-07-2019	06-30-2019	10-Q
27	05-10-2019	03-31-2019	10-Q
28	03-07-2019	12-31-2018	10-K
29	11-07-2018	09-30-2018	10-Q
30	08-07-2018	06-30-2018	10-Q
31	05-08-2018	03-31-2018	10-Q
32	03-08-2018	12-31-2017	10-K
33	11-07-2017	09-30-2017	10-Q
34	08-08-2017	06-30-2017	10-Q
35	05-05-2017	03-31-2017	10-Q
36	03-10-2017	12-31-2016	10-K
37	11-09-2016	09-30-2016	10-Q
38	08-09-2016	06-30-2016	10-Q
39	05-10-2016	03-31-2016	10-Q
40	03-10-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Ocular Therapeutix Q3 EPS $(0.38) Misses $...
11/04/2025 12:06:26

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of ...

Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

TD Cowen Maintains Buy on Ocular Therapeut...
10/30/2025 20:14:02

TD Cowen analyst Tara Bancroft maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target from $14 to...

eli-lilly-to-rally-more-than-12-here-are-10-top-analyst-forecasts-for-wednesday

Eli Lilly To Rally More Than 12%? Here Are...
10/08/2025 14:04:25

HC Wainwright & Co. Maintains Buy on Ocula...
10/08/2025 10:16:00

HC Wainwright & Co. analyst Yi Chen maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target fr...

Piper Sandler Maintains Overweight on Ocul...
10/03/2025 15:11:38

Piper Sandler analyst Biren Amin maintains Ocular Therapeutix (NASDAQ:OCUL) with a Overweight and raises the price target fr...

Baird Maintains Outperform on Ocular Thera...
10/03/2025 11:43:22

Baird analyst Colleen Kusy maintains Ocular Therapeutix (NASDAQ:OCUL) with a Outperform and raises the price target from $17...

Chardan Capital Maintains Buy on Ocular Th...
10/02/2025 12:30:05

Chardan Capital analyst Daniil Gataulin maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and maintains $21 price target.

Needham Maintains Buy on Ocular Therapeuti...
10/01/2025 18:24:50

Needham analyst Serge Belanger maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target from $15 to...

Expert Outlook: Ocular Therapeutix Through...
10/01/2025 14:02:23

JMP Securities Maintains Market Outperform...
10/01/2025 12:46:21

JMP Securities analyst Jonathan Wolleben maintains Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and raises the ...

Ocular Therapeutix Raises $475M In Stock O...
09/30/2025 11:11:38

Ocular Therapeutix, Inc. (NASDAQ:OCUL) ("Ocular", the "Company"), an integrated biopharmaceutical company commi...

Ocular Therapeutix Showcases Progress On N...
09/30/2025 10:22:48

Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular"))), an integrated biopharmaceutical company committed to redefining the...

this-broadcom-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday

This Broadcom Analyst Begins Coverage On A...
09/15/2025 11:22:08

Chardan Capital Initiates Coverage On Ocul...
09/15/2025 10:21:31

Chardan Capital analyst Daniil Gataulin initiates coverage on Ocular Therapeutix (NASDAQ:OCUL) with a Buy rating and announc...

Ocular Therapeutix Receives Written Agreem...
08/12/2025 11:10:01

Scotiabank Maintains Sector Outperform on ...
08/06/2025 16:35:52

Scotiabank analyst Greg Harrison maintains Ocular Therapeutix (NASDAQ:OCUL) with a Sector Outperform and lowers the price ta...

Ocular Therapeutix Q2 EPS $(0.39) Misses $...
08/05/2025 11:02:50

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of ...

Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

What's Next: Ocular Therapeutix's Earnings...
08/04/2025 20:04:10